Association between malignant progression of colorectal adenomas and DNA replication error and inhibition of apoptosis
Association between malignant progression of colorectal adenomas and DNA replication error and inhibition of apoptosis
批准号:
07671437
负责人:
WATATANI Masahiro
金额:
$1.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The aim of this study is to investigate the association between malignant potency of colorectal adenomas to progress to carcinoma and the inhibition of apoptosis and DNA replication errors in colorectal adenomas. We examined p53 and bcl-2 overexpression, and analyzed dinucleotide instability in colorectal adenomas showing various degree of dysplasia and carcinomas invading submucosa. Overexpression of p53 was associated with progression dysplasia and depth of cancer invasion. However, the frequency of bcl-2 overexpression was not increased according to the degree of dysplasia. We also studied p21 WAF1 and PCNA expression in adenomas with various degree of dysplasia and carcinomas with submucosal invasion, and investigated whether the irregularity of cell cycle was related to the development of colorectal tumors. In adenomas showing high grade dysplasia, the PCNA labeling index in adenomas which were positive for p21 WAF1 and negative for p53 overexpression was significantly lower than in adenomas which were both positive for p21 WAF1 and p53 overexpression. These results suggest that proliferation of some of adenomas with high grade dysplasia might be suppressed by p21 WAF1 expression which was induced irrespective of p53 expression. The analysis of genetic alterations in carcinomas showed that 27% of 87 tumors had DNA replication error. We undertook analysis of DNA replication error in DNAs from formalin-fixed paraffin-embedded adenomas, but efficiency of PCR amplification of such DNAs was not so good to perform the study. Further study is necessary to clarify the role of DNA replication error in colorectal carcinogenesis.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
黒田幸作,綿谷正弘: "大腸癌進展における遺伝子変化" 癌と化学療法. 23. 164-168 (1996)
Kosaku Kuroda、Masahiro Wataya:“结直肠癌进展中的基因变化”《癌症与化疗》23. 164-168 (1996)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S. Ieda: "Immunohistochemical analysis of p53 and ras p21 expression in colorectal adenomas with varying degrees of dyoplasia and early carcinomas with and without adenomatous component" Surgery Today. (印刷中).
S. Ieda:“具有不同程度的不典型增生的结直肠腺瘤和具有或不具有腺瘤成分的早期癌中 p53 和 ras p21 表达的免疫组织化学分析”《今日外科》(正在出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
家田真太郎: "大腸癌術後に発生する異時性腺腫は発癌性が強いが" 消化器癌の発生と進展. 6. 89-92 (1994)
Shintaro Ieda:“结直肠癌手术后发生的异时性腺瘤具有高度致癌性”,胃肠癌的发生和进展(1994)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Yoshida, M.Watatani: "Relationship of changes of p53 gene and microsatellite instability toprogression of colorectal cancer." Acta Med kinki Univ. 20(4). 369-376 (1995)
T.Yoshida,M.Watatani:“p53 基因和微卫星不稳定性的变化与结直肠癌进展的关系。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M.Watatani, et al: "Bcl-2 and p53 expression in metachronous colorectal adenomas compared with initial adenomas in relation to the degree of dysplasia" Recent advanced in Gastronterological carcinogenesis. 371-375 (1996)
M.Watatani 等人:“异时结直肠腺瘤中 Bcl-2 和 p53 的表达与异型增生程度的初始腺瘤相比” 胃肠癌发生的最新进展。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 24 条
Isolation of mammary cancer stem cell and analysis of its molecular biology for targeted chemotherapy in breast cancer
-
批准号:18591447
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.79万
-
财政年份:2006
-
负责人:WATATANI Masahiro
-
依托单位:
A new staging of breast cancer patients with genetic alterations
-
批准号:11671196
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.73万
-
财政年份:1999
-
负责人:WATATANI Masahiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: